Physician profile
Nathan B Smith
NPI 1154309326
$3,079.58
in general payments reported to CMS, 2019-2025
18 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $1,049 · 2023: $442 · 2024: $759 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560 · Education: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,560.23 |
| Education | $204.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,001.53 | 2022 | |
| Janssen Biotech, INC. | $630.35 | 2021-2025 | Tremfya, Simponi, Stelara |
| Abbvie INC. | $459.05 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $195.22 | 2023-2024 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $165.52 | 2021-2025 | |
| Amgen INC. | $137.85 | 2023-2025 | Otezla |
| Ucb, INC. | $113.44 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $94.12 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $54.55 | 2023-2024 | Dupixent |
| Sun Pharmaceutical Industries INC. | $47.65 | 2025 | |
| Fresenius Kabi USA, LLC | $39.06 | 2023 | Idacio |
| Genzyme Corporation | $33.61 | 2025 | |
| Biofrontera INC. | $30.06 | 2021 | |
| Incyte Corporation | $18.19 | 2024 | Opzelura |
| Galderma Laboratories, L.P. | $15.46 | 2025 | Nemluvio |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.95 | 2022 | |
| Strata Skin Sciences, INC. | $14.73 | 2023 | Xtrac |
| Dermavant Sciences, INC. | $14.24 | 2024 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.